The FDA outdid itself last year, granting first-time approvals to 43 new biotech-derived medicines and 36 supplemental indications for drugs and biologics developed by specialty and big pharma companies as well as biotech firms. More
The results of a study, carried out by Lowendal UK, has found out that large pharmaceutical companies are losing millions of pounds every year because of a failure to keep track of vital hospital consignment stock. More
The economic, structural, political and health dynamics that impact growth are rebalancing the worldwide pharmaceutical market, driving global growth of 5-6% for 2007, according to IMS Health. More